Observational studies at the SCAI meeting favored the dual GIP/GLP-1 receptor agonist tirzepatide (Mounjaro, Zepbound) over ...

Although my bias as a CAS enthusiast makes me believe that CAS will ultimately have a major role in the treatment of patients with carotid stenosis, and although results of CAS will ultimately ...

For patients with carotid stenosis ≥50% with a low/intermediate predicted stroke risk, there is no benefit for revascularization added to OMT.

Aortic stenosis is a progressive and potentially fatal condition, affecting about five per cent of 65-year-olds in the US -- with increasing prevalence in advancing age. Symptoms include chest ...

A transcatheter aortic valve replacement (TAVR) therapy was approved by the US Food and Drug Administration (FDA) for patients with severe aortic stenosis even without symptoms. This is the first ...

In symptomatic carotid stenosis, treatment decisions are currently primarily based on stenosis degree. We developed a clinical prediction model (Individualized Magnetic Resonance Imaging–Based Stroke ...

is beneficial for patients with carotid stenosis, particularly those with a predicted absolute risk of ipsilateral stroke of less than 20% over 5 years. ECST-2 is a 5-year, randomised, open-label ...

Correspondence to Professor Leo H Bonati, Department of Neurology and Stroke Center, University Hospital Basel, Basel, Switzerland; leo.bonati{at}outlook.com Background and purpose Carotid artery ...

Join MIMS now and pay nothing for the first 30 days Join GPOnline now and pay nothing for the first 30 days ...

UEA research reveals how an MRI scan can diagnose aortic stenosis more reliably than current ultrasound techniques. UEA scientists have developed cutting-edge MRI technology to diagnose a common heart ...

Background It is debated whether endovascular treatment is indicated for a symptomatic chronically occluded internal carotid artery (COICA). Objective To assess outcomes after endovascular treatment ...